(Q33845821)

29 July 2017

title

Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA. (English)

1 reference

29 July 2017

1 reference

7

Nappi G

1 reference

29 July 2017

Martignoni E

1

1 reference

29 July 2017

Blandini F

2

1 reference

29 July 2017

Godi L

3

1 reference

29 July 2017

Desideri S

4

1 reference

29 July 2017

Pacchetti C

5

1 reference

29 July 2017

Mancini F

6

1 reference

29 July 2017

publication date

1 August 1999

1 reference

29 July 2017

number of pages

10

1 reference

Free Radical Biology and Medicine

inferred from page(s)

published in

1 reference

29 July 2017

volume

27

1 reference

29 July 2017

issue

3-4

1 reference

29 July 2017

page(s)

428-437

1 reference

Oxidative damage in neurodegenerative disease

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Oxidative stress and the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Superoxide dismutase expression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Changes of respiratory chain activity in mitochondrial and synaptosomal fractions isolated from the gerbil brain after graded ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Selegiline and lymphocyte superoxide dismutase activities in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Increased erythrocyte susceptibility to lipid peroxidation in human Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Oxygen free radical producing activity of polymorphonuclear leukocytes in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Levodopa induces apoptosis in cultured neuronal cells--a possible accelerator of nigrostriatal degeneration in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Carbidopa/levodopa and selegiline do not affect platelet mitochondrial function in early parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Toxic and protective effects of L-dopa on mesencephalic cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Levodopa: is toxicity a myth?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Separation of dihydroxybenzoates, indicators of in-vivo hydroxyl free radical formation, in the presence of transmitter amines and some metabolites in rodent brain, using high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP+

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation by monoamine oxidase inhibitor in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Platelet Activation by Superoxide Anion and Hydroxyl Radicals Intrinsically Generated by Platelets That Had Undergone Anoxia and Then Reoxygenated

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Quantitative study of mitochondrial complex I in platelets of parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Hydroxylation of salicylate by microsomal fractions and cytochrome P-450. Lack of production of 2,3-dihydroxybenzoate unless hydroxyl radical formation is permitted

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

High-performance liquid chromatography-electrochemical determination of salicylate hydroxylation products as an in vivo marker of oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

Dopamine agonists and neuroprotection in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900075-1

7 January 2021

10.1016/S0891-5849(99)00075-1

Identifiers

DOI

1 reference

29 July 2017

1 reference